RecruitingNCT05146336
CytOSorb TreatMent Of Critically Ill PatientS Registry
CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting
Sponsor
CytoSorbents, Inc
Enrollment
3,000 participants
Start Date
Jun 22, 2022
Study Type
OBSERVATIONAL
Conditions
SepsisLiver Transplant; ComplicationsPancreatitisAcute-On-Chronic Liver FailureCardiogenic ShockSeptic ShockTraumaHemophagocytic LymphohistiocytosesAcute Respiratory Distress SyndromeRhabdomyolysisAcute Liver FailureBurnsChimeric Antigen Receptor T-Cell Therapy (CAR-T) Cytokine Release Syndrome (CRS)Extracorporeal Life SupportPostoperative EndocarditisInfectious DiseasePostoperative Vasoplegic SyndromeDrug Overdose
Summary
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care
Eligibility
Inclusion Criteria2
- Planned OR actual CytoSorb® 300 mL device utilization
- Informed consent for prospective registry participation
Exclusion Criteria3
- Use of the CytoSorb® 300 mL device for antithrombotic removal only
- Intraoperative use of CytoSorb® 300 mL device during cardiac surgery only
- The occurrence of a complication or other medically justified circumstance that arises after written informed consent has been obtained from the patient and before or during the planned therapy and as a result of which the use of CytoSorb® 300 mL Adsorber is contraindicated or no longer appropriate.
Interventions
DEVICECytoSorb
Sorbent hemoperfusion system
Locations(28)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05146336
Related Trials
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
NCT044194801 location
Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome
NCT074508461 location
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
NCT072939235 locations
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT0568144228 locations
Safe and Explainable AI
NCT066941811 location